key: cord-0716379-43pqf2kx
authors: Dai, Jun; Wang, Huan; Liao, Ying; Tan, Lei; Sun, Yingjie; Song, Cuiping; Liu, Weiwei; Qiu, Xusheng; Ding, Chan
title: Coronavirus Infection and Cholesterol Metabolism
date: 2022-04-21
journal: Front Immunol
DOI: 10.3389/fimmu.2022.791267
sha: 87905f250df11e37c40eb91b667db7ac91f7fb97
doc_id: 716379
cord_uid: 43pqf2kx

Host cholesterol metabolism remodeling is significantly associated with the spread of human pathogenic coronaviruses, suggesting virus-host relationships could be affected by cholesterol-modifying drugs. Cholesterol has an important role in coronavirus entry, membrane fusion, and pathological syncytia formation, therefore cholesterol metabolic mechanisms may be promising drug targets for coronavirus infections. Moreover, cholesterol and its metabolizing enzymes or corresponding natural products exert antiviral effects which are closely associated with individual viral steps during coronavirus replication. Furthermore, the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 infections are associated with clinically significant low cholesterol levels, suggesting cholesterol could function as a potential marker for monitoring viral infection status. Therefore, weaponizing cholesterol dysregulation against viral infection could be an effective antiviral strategy. In this review, we comprehensively review the literature to clarify how coronaviruses exploit host cholesterol metabolism to accommodate viral replication requirements and interfere with host immune responses. We also focus on targeting cholesterol homeostasis to interfere with critical steps during coronavirus infection.

Coronaviruses are enveloped viruses with non-segmented, single-stranded, positive sense RNA genomes (1) . They belong to the Nidovirales order in the Coronaviridae, and are divided into four types: a, b, g, and d (1, 2) . Coronavirus subfamily members are widespread in infected birds and mammals and some respiratory and intestinal diseases (3) (4) (5) . Currently, at least seven coronaviruses are known to infect humans, including respiratory syndrome coronavirus 2, human coronavirus OC43, human coronavirus NL63, human coronavirus 229E, severe acute respiratory syndrome coronavirus, human coronavirus HKU1, and Middle East respiratory syndrome coronavirus (6) . Coronavirus diversity is due to the low fidelity of RNA-dependent RNA polymerase during viral coding which produces approximately 10 −3 -10 −5 substitutions/site/year (7) . Previous evidence indicated that coronaviruses undergo rapid recombination which creates new strains with altered virulence (8) . Recent studies reported molecular and serological evidence of the active transmission Previous studies reported that COVID-19 severity was related to several risk factors, for example, obesity, old age, and underlying disease (47) (48) (49) . A recent study suggested that when compared to the normal population, cholesterol levels were significantly lower in COVID-19 patients (50) . Furthermore, high-density lipoprotein cholesterol was lower in patients with severe and critical disease than in patients with moderate or mild disease, in a study on cholesterol metabolism in mild, moderate, severe, and critical COVID-19 patients (51) . Age-specific COVID-19-associated death data from 45 countries showed that the infection fatality ratio was lowest among 5-9year-old children, with a log-linear increase by age in individuals over 30 years old (52) . In Spanish subjects over 75 years old, the lethality rate approached 36% in hospitalized patients, far higher than for younger groups under the same conditions in hospitals, despite having s similar course to younger individuals (53) . In addition, Richter and Sohrabi studied obese factors in COVID-19 patients when compared with the normal population. In general, they observed that obese patients were twice as likely to develop COVID-19 as those with a normal weight range (54, 55) . A study of clinical characteristics on 393 patients with COVID-19 in New York City, they found that respiratory failure, a severe clinical symptom of COVID-19, was more common among the obese patient subgroup, comprising 35.8% of the patients studied in New York. In addition, they also found that after advanced age, obesity was the most common risk factor leading to severe disease and death from COVID-19 (56) . In addition to these factors, male sex, diabetes, smoking, hypertension, and cardiovascular disease also affect COVID-19 risk severity.

Importantly, transcriptomics data indicated that host cholesterol metabolism affects virus replication (57) . Cholesterol content in the plasma membrane is extremely high and is important for biochemical and biophysical functions (58) . As a unique feature of mammalian membranes, host cell cholesterol is targeted by pathogens (cytosolic bacteria and viruses) for entry and egress (59) (60) (61) (62) (63) , however, a small number of coronavirus strains are distinct in terms of their dependence on cholesterol (64) . Notwithstanding, a strong relationship between cholesterol and coronavirus replication is widely documented in the literature; in some instances, cholesterol is vital for coronavirus entry, membrane fusion, translation, pathological syncytia formation and vascular pathology (65-68) (Figure 1 ). Cholesterol metabolism may be hijacked by enveloped viruses to provide raw materials for virus particle replication, assembly, and maturation (69), e.g., Hepatitis C virus (HCV), human cytomegalovirus, and Epstein-Barr virus (70) (71) (72) . For coronaviruses, cholesterol and other specific lipid requirements are required for viral replication scaffolds (73) (74) (75) . Also, previous studies reported significant associations between cholesterol homeostasis and type I interferon (IFN) responses (76) . Viral infections may induce host cells to alter the expression of cholesterol metabolizing enzymes and metabolites, and similarly, cholesterol metabolism can also regulate host antiviral responses (77, 78) . Therefore, weaponizing host cholesterol metabolism dysregulation against coronavirus infectivity could be an effective antiviral strategy (79, 80) .

Thus, cholesterol could be an important tool for the in-depth exploration of COVID-19 pathophysiology (81) . The disruption of cholesterol homeostasis may interfere with critical steps of coronavirus infection, therefore understanding cholesterol functions during COVID-19 pathogenesis may generate improved prognostics and therapeutics (27) . Recently, Daniloski et al. conducted a large-scale screen of > 20,000 drugs potentially used to treat COVID-19, and identified cholesterol biosynthesis pathway induction as a possible mechanism of viral inhibition (82, 83) . The pharmacological inhibition of phosphatidylinositol kinases and cholesterol homeostasis reduced replication of all three coronaviruses. These findings provide important insights for an increased understanding of the coronavirus life cycle and the development of host-directed therapies (84) . This review focuses on the latest scientific evidence and clarifies how coronaviruses manipulate host cholesterol metabolism to meet their own replication needs and impair host IFN responses. In addition, targeting and altering cholesterol levels in host cell membranes, and interfering with intracellular cholesterol metabolism pathways may be effective strategies in preventing early coronavirus cell entry and subsequent translation and replication. These approaches could provide foundations for the design of anti-coronavirus drug and treatment strategies (79, 85) .

Coronavirus entry into host cells is key for virus replication cycles and evading host antiviral responses (86, 87) . However, coronaviruses enter cells by two ways: 1) when sufficient proteases are present on plasma membranes, viruses exploit this by fusing with the cell through the "early pathway" via the plasma membrane, and 2) in the absence of extracellular proteases, endosomal proteases activate the viral S protein to FIGURE 1 | Disrupting cholesterol homeostasis interferes with critical steps during coronavirus infection. Cholesterol is important for coronavirus attachment (A), endocytosis (B), membrane fusion (C), translation/replication (D), and maturation/release (E). 25HC, 25-hydroxycholesterol; MbCD, methyl-beta-cyclodextrin; LE/MVB, late Endosomes/Multivesicular Bodies; IFITM3, interferon-induced transmembrane protein-3; U18666a, an intra-cellular cholesterol transport inhibitor; DMVs, double-membrane vesicles; OSBP, oxysterol-binding protein; VAP-A, vesicle-membrane-protein-associated protein A; Oxy210, semi-synthetic oxysterols; Oxy232, semi-synthetic oxysterols; AM580, a selective retinoic acid receptor-a agonist.

gain cell entry via the endosomal pathway (88) which is sensitive to the pH of endosome/lysosome pathways (89) . Moreover, the infection efficiency of SARS-CoV in the cell in the "early pathway" is 100-1000 times higher than the endosomal pathway (90) . Previous research reported that many coronaviruses, including infectious bronchitis virus (IBV), porcine hemagglutinating encephalomyelitis virus (PHEV), porcine epidemic diarrhea virus (PEDV), and feline coronavirus (FCoV) enter host cells via the endocytic pathway and then pass-through endosomal compartments via multivesicular bodies (MVBs) to enter the cytoplasm (91) (92) (93) (94) . The coronavirus S protein plays a key role in early viral infection stages and is necessary for viral entry and chemotaxis in hosts (95) . This protein is a type I homotrimeric transmembrane fusion glycoprotein, composed of S1 and S2 subunits with different functions. The RBD of the S1 subunit recognizes the cell receptor, ACE2, which determines cell homogeneity and pathogenicity of coronaviruses. The S2 subunit mediates virus and host cell membrane fusion via a wide range of conformational rearrangements (96) (97) (98) . Moreover, the S1 subunit of SARS-2-S also binds to cholesterol and possibly high-density lipoprotein (HDL) components to enhance in vitro viral uptake; this mechanism is mediated by the HDL scavenger receptor B type 1 (99) . In addition, the SARS-CoV-2 spike protein S1/S2 boundary sequence has key roles in regulating viral entry and spread within the cell (96) . More importantly, S1/S2 border sequence deletion switches SARS-CoV-2 from the plasma membrane to the endosomal fusion pathway, significantly reducing viral transmission efficiency in hamsters (100) . In particular, the S1/S2 boundary sequence contains a furin protease cleavage site which pre-activates the S protein for membrane fusion, reducing SARS-CoV-2 dependence on plasma membrane proteases (e.g., TMPRSS2), thereby efficiently improving cell entry (101) . When compared with other coronaviruses, murine coronavirus (MHV) is unique; its receptor binding has dual roles when gaining cell entry: the S protein N-terminal domain binds to the host receptor protein, CEACAM1a (102), then MHV uses a zinc metalloprotease for invasion and cell-cell fusion (103) . This not only promotes MHV attachment to host cells, but also promotes MHV fusion with the host membrane (104) . More specifically, the CEACAM1 receptor or a pH 8 induces conformational changes in the MHV S glycoprotein at 37°C. This conformational change is more conducive to triggering membrane fusion without the need to activate cleavage between S1 and S2 in advance (105) .

Niemann-Pick disease type C (NPC) is a lysosomal storage disorder (106) caused by deficient lipid efflux from the late endosome/lysosome (LE/L) and induces intracellular cholesterol synthesis and transport disorders to impair viral SARS-CoV-2 infectivity via several lipid-dependent mechanisms (79) . By intervening in the NPC1 pathway, SARS-CoV-2 is blocked from entering the host cell from the plasma membrane or endosomes/ lysosomes, thus viral infectivity is weakened (107) . The Ebola virus requires a functional NPC1 protein to complete its replication cycle, however, it is unclear if this is true for coronaviruses (108) . Studies reported that SARS-CoV particle transport through endosomes to NPC1 positive compartments of the lysosomal system was necessary for successful infection (109) . Mingo et al. showed that Ebola virus reaching NPC1-positive LE/Ls was the rate-limiting step in determining viral infection (109) . Furthermore, although SARS-CoV does not require NPC1 for entry, its entry into the cytoplasm begins after colocalization with NPC1 (109). Therefore, pharmacological interventions targeting lysosomal functions could induce transient NPC1-like cells and biochemical phenotypes, which could constitute a possible rationale for COVID-19 treatment (110) . Drugs such as fluoxetine not only damage LE/L acidification but also accumulate cholesterol in these compartments (111) .

Coronavirus enters host cells mainly via plasma membrane fusion or endocytosis (112, 113) . Lipid rafts participate in endocytosismediated processes, and function as platform and docking sites for coronavirus entry and genome release (114, 115) . Cholesterol is an important component of lipid rafts; increased lipid raft formation is benefitted by increased cholesterol levels (116) . Early coronavirus infection depends on lipid rafts (117) which may harbor ACE2 receptors for the SARS-CoV-2 S protein (118) (119) (120) (121) , permitting membrane rearrangements to facilitate transmissible gastroenteritis virus (TGEV) entry (122) . In addition, lipid rafts act as attachment factors to promote IBV absorption before it enters the cell (119) . MHV entry and membrane fusion also require lipid rafts (123) . Membrane cholesterol consumption inhibits SARS-CoV-2 and other coronaviruses from fusing with cells, preventing viral entry (124, 125) . By reducing plasma membrane cholesterol levels and changing lipid raft-dependent ACE2 and TMPRSS2 activities, these processes interfere with viral internalization by host cells (87, 110, 126) . Therefore, cholesterol depletion from cellular membranes using e.g., methyl-b-cyclodextrin (MbCD) eliminates cholesterol in lipid rafts and significantly reduces clathrin-dependent endocytosis to significantly eliminate IBV, TGEV, and SARS-CoV infectivity ( Figure 1A ) (117, 119, 127) . In addition, SARS-CoV-2 pathogenicity was significantly dependent on TMPRSS2 (128) . Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19 (129) . The SARS-CoV-2 Omicron variant showed less efficient replication and fusion activity when compared with the Delta variant in TMPRSS2-expressed cells (130) . Omicron infection was not enhanced by TMPRSS2 but was largely mediated by the endocytic pathway. The differences in pathway entry between variants may have impacted on clinical manifestation or disease severity (130) . In addition, anti-androgens target TMPRSS2 and reduce SARS-CoV-2 virus entry in lung cells (131) , which may at least in part explain why men with COVID-19 have a worse prognosis when compared to women (132) . SARS-CoV-2 cell entry inhibition via TMPRSS2 was facilitated by camostat, nafamostat mesylate and alpha-1 antitrypsin (133, 134) . It is therefore possible that inhibiting androgen signaling by anti-androgens could reduce TMPRSS2 expression in the lung, and concomitantly reduce viral entry. For this reason, anti-androgens are proposed as treatment options for COVID-19 (135, 136) . Infectivity is also reduced by depleting cholesterol from the viral envelope as in TGEV (127) . Similarly, plasma membrane cholesterol depletion is also triggered by ACE2 displacement from lipid rafts to non-raft membrane domains, thereby reducing efficient SARS-CoV cell entry (120) . Previous studies reported that 27-hydroxycholesterol (27HC) accumulation in lipid rafts caused the rapid consumption of lipid raft cholesterol, interrupted cell signal transduction in lipid raft membrane microdomains, and specifically inhibited IL-6-JAK-STAT3 signaling (137, 138) . It is worth emphasizing that lipid raft destruction due to cholesterol consumption may be the main reason for inhibiting extracellular signal-regulated kinase (ERK) signaling and activation inhibition (139) . Since the Raf/MEK/ ERK pathway is involved in the modulation of various important cellular functions, numerous DNA and RNA viruses coopt this pathway for efficient viral propagation (140) . The ERK pathway is known to be modulated during PEDV infection (141) . In our previous research, we reported that IBV infection activated ERK1/2 signaling and that up-regulation of the phosphatase, DUSP6 formed a negative regulation loop (142) . ERK activation is necessary for PEDV and porcine deltacoronavirus (PDCoV) replication, the suppression of viral protein expression, and viral RNA transcription via ERK activation inhibition (140, 143) . Also, the negative regulation of the Raf/MEK/ERK signaling pathway by the MEK inhibitor, U0126 or DUSP6 upregulation significantly impairs MHV and IBV progeny production (142, 144) , respectively. However, the exact mechanism whereby ERK activity regulates the replication cycle of PEDV during infection remains unclear. Therefore, the targeted regulation of lipid raft cholesterol levels may be a host defense strategy against coronavirus infection (145) .

Along with binding to host cell receptors, viral envelope fusion with host cell membranes is critical in establishing successful coronavirus infection, especially for viral gene delivery into the cytoplasm. Coronaviruses enter cells by fusing directly with the cell surface or internalization via endosomal membranes (146) . In general, the viral envelope contains specific cholesterol quantities; cholesterol is an important component of lipid rafts, and the fusion of viruses and host plasma membranes is affected by the ratio of membrane cholesterol to fatty acids (147) . Genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screening revealed that cholesterol metabolism was a key host pathway promoting coronavirus (SARS-CoV-2, HCoV-229E, and HCoV-OC43) infections (84), whereas cholesterol dysregulation reduced viral invasion (82, 84, 100, 148) . In addition, coronavirus enters cells either via fusion or endocytosis (149) via clathrinmediated mechanisms in a cholesterol dependent manner ( Figure 1B) (92) . Cellular cholesterol homeostasis regulation, especially in endosomal compartments, exerts a significant impact on the entry stage of viral infection (108) . It is because that coronavirus or coronavirus-containing MVBs via the endosomal cathepsin activate viral S protein to mediate the cytoplasmic release of viral nucleic acid, and artificially destroying the homeostasis of cholesterol in the endosomal membrane will inhibit this invasion step (91, 150) . Therefore, the virus reprograms cholesterol metabolism to promote virus replication, or specific infectioninduced host defense responses. Targeting cholesterol metabolism pathways in cells could be a potential target for interfering with "viral cargo", and may be used as an intervention to inhibit coronavirus membrane fusion in the endosome (79) . Many coronaviruses, including IBV, PHEV, PEDV, and FCoV pass through endosomal compartment via MVBs to enter the cytoplasm (91) (92) (93) (94) . In a previous study, IBV membrane fusion was induced in the LE/L after 1 hour post infection (91) . The accumulation of cholesterol and oxidized sterols in late endosomes and MVBs also impaired virus functions, hindered viral membrane fusion, and subsequent replication (79, 151) . Therefore, the destruction of cholesterol homeostasis to block viral entry exemplifies the importance of cholesterol during viral infections (150) . Cholesterol function during viral invasion was extensively studied in several coronaviruses, including SARS-CoV (120), PEDV (152) , MHV (123, 153) , PDCoV (154) , and IBV (117, 119) .

Coronavirus infections may be significantly restricted by IFNinduced transmembrane proteins (IFITMs) (155) . These proteins significantly inhibit endosome membrane fusion and are driven by the viral S protein (156) . IFITMs inhibit viral membrane fusion before hemifusion occurs, by reducing membrane fluidity and imparting positive spontaneous curvature to outer cell membrane leaflets (157) . IFITM phosphorylation status and carboxy-terminal amino acid residues are key factors determining human coronavirus entry, including, HCoV-NL63, SARS-CoV, MERS-CoV, HCoV-OC43, and MERS-CoV (158) . These functional units may pass it interacts with the virus and/or host cell components of the virus entry site to regulate the fusion of the virus envelope and cell membrane (158) The vesicle membrane-associated protein A (VAPA) and oxysterol-binding protein (OSBP) jointly regulate intracellular cholesterol balance (150) . IFITM3, as a member of the IFITM protein family, hinders binding of OSBP and VAPA, which not only causes abnormal cholesterol accumulation in late endosomes, but also increases membrane hardness and inhibits viral nucleic acid release ( Figure 1C ) (150) .

As a positive-strand RNA virus, after internalization and uncoating, coronavirus first uses its own genomic RNA as a template to replicate and produce the polyproteins, pp1a and pp1ab via cap-dependent translation, and then via autoproteolytic cleavage, 15-16 nonstructural proteins (NSPs) (159) . NSPs induce the rearrangement of cholesterol-rich lipid rafts on cell membranes, forming double-membrane vesicles (DMVs) in the cytoplasm, thereby anchoring viral replication transcription complexes (160) . DMVs act as efficient replication sites for coronavirus genomic RNA and provide a safe site for viral RNA replication and translation (161) . Cholesterol is also enriched in DMVs and constitutes the viral replication site of DMVs with fatty acids (80, 162) . DMVs destroyed by Oxy210 (semi-synthetic oxysterol) significantly inhibit SARS-COV-2 replication in vitro (163) ( Figure 1D) . Thus, disruption of lipid rafts may affect viral replication and transcriptional synthesis. Recently, it was reported that intracellular cholesterol biosynthesis and transport systems were related to virus replication (164) (165) (166) . Cellular cholesterol is derived from the biosynthesis and cellular uptake of low-density lipoprotein (167) (168) (169) . U18666A is a cationic amphiphilic drug affecting cholesterol biosynthesis and intracellular transport (170) . Previous studies reported that cholesterol was involved in the viral life cycle of type I FCoV infection (64) , and that U18666A induced cholesterol accumulation via NPC1 dysfunction and type I FCoV replication inhibition (144, 171, 172) .

After un-coating, translation, and genome replication, virus particles assemble in the endoplasmic reticulum (ER)-Golgi intermediate compartment and are coordinated by the M protein (159, 173) . For most coronaviruses, virus assembly sites contain highly active enzymes involved in the cholesterol biosynthesis pathway; these include, cholesterol-synthesizing enzyme, 3-hydroxy-3-methyl glutaryl coenzyme A reductase, and mevalonate diphospho decarboxylase (165, 174, 175) . Several studies indicated that many enveloped viruses, such as human immunodeficiency virus, Dengue, Zika, and alphavirus contain cholesterol in the virion, and that viral proteins involved in virus particle assembly and budding are related to cholesterol (78, 176) . Furthermore, different cholesterol levels in hosts generate different envelope cholesterol levels in alphaviruses (177) . When compared with mayaro virus particles from mosquito cells, virus particle envelopes from vertebrate cells have higher cholesterol levels (178) . In terms of coronaviruses, Simons et al. found that although MHV-S protein was localized to the Golgi, that contained cholesterol and lipid rafts, the assembled and released of MHV is not associated with cholesterol (167) . But, cholesterol involvement in virus assembly and budding has mainly focused on viruses budding from cell membranes, however, studies on viruses budding from intracellular membranes are rare (167) . Moreover, the different functional roles of cholesterol in enveloped RNA virus stability, infectivity, and assembly are not entirely clear (177, 179) . Therefore, coronavirus assembly and budding may not necessarily use cholesterol on Golgi membranes, thus specific mechanisms require further study.

Coronavirus infection induces host cells to alter the expression of certain cholesterol metabolizing enzymes and metabolites which may exert antiviral effects (Figure 2A ) (77) . Indeed, both 25hydroxycholesterol (25HC) and 27-hydroxycholesterol (27HC) are physiologically produced by the enzymatic oxidation of cholesterol and may be used to inhibit enveloped and nonenveloped human viruses (183, 184) and highly pathogenic viruses, including Zika (185), mammalian reovirus (186), Lassa virus (187), encephalomyocarditis virus (188), porcine reproductive and respiratory syndrome virus (189) . A recent study reported that the 25HC treatment of mice infected with SARS-CoV-2 significantly reduced virus numbers in the lungs and trachea (148) . On the one hand, cholesterol is transformed into 25HC by Cholesterol 25-Hydroxylase (CH25H). By obstructing membrane fusion, 25HC exhibits extensive anti-coronavirus activity (125, 184) . Similarly, the internalization of 25HC aggregates in late endosomes may inhibit spike protein-catalyzed membrane fusion of SARS-CoV-2 by blocking cholesterol export (124) ; however, CH25H consumes available cholesterol on the plasma membrane to suppress virus-cell fusion (125) . These data indicate that membrane-modifying oxysterols are possible antiviral therapeutics, thereby inhibiting SARS-CoV-2 and other coronaviruses ( Figure 1A ) (153) . However, it is possible to obstruct PDCoV proliferation using CH25H which acts as a host restriction factor, but this inhibition is not entirely dependent on its enzymatic activity (190) . The junction adhesion molecule-A and the cation independent isoform of the mannose-6-phosphate receptor are two key replication molecules common to all viruses that use adhesion molecules and the endosomal pathway to enter and diffuse target cells. Both molecules are downregulated by 25HC and 27HC (191) . Previous studies suggested that SARS-CoV-2 propagation in cultured cells was inhibited by various cholesterol molecules, including natural oxysterols, 7-ketocholesterol, 22(R)hydroxycholesterol, 24(S)-hydroxycholesterol, and 27HC (Figures 2A-e, c) (163) . At effective concentrations, 25HC, 7dehydrocholesterol (7DHC), and 27HC were non-toxic natural products, with potentially curative applications for emerging virus infections, such as SARS-CoV-2 (192) 

All coronaviruses have a similar infection mechanism, which successfully manipulates host cell functions. One strategy to suppress the host innate immune response to evade antiviral responses, is shielding RNA intermediates in replication organelles (193, 194) . In fact, coronaviruses with +RNA genomes, which duplicate solely in the cytoplasmic matrix, and modify the inner membranes of cells to form virus duplication bases, also known as "replication factories" or "replication organelles". While varying in morphology and membrane composition, these structures appear to centralize viral replication machinery, intermediates, and products in membrane-bound vesicles or invaginations, and are beyond the reach of innate immune sensors in the cytosol. Thus, viral infection outcomes are determined by metabolic interactions between hosts and viruses (195) . Cholesterol is a crucial component of cell membranes and lipid rafts. Cholesterol metabolism contributes to the formation of immune synapses and downstream signal transmission (196) .The host's defenses against virus infection requires IFN-mediated cholesterol biosynthesis and the formation of immune synapses, and also host innate immune metabolic regulators as potential antiviral strategies (197) .

Two molecules, sterol regulatory element-binding protein-2 (SREBP-2) and 3-hydroxy-3-methyglutaryl CoA reductase (HMGCR), have significant roles in the cholesterol biosynthetic pathway; SREBP-2 is the master transcriptional regulator of cholesterol biosynthesis (Figures 2B-e, g) and HMGCR is a rate-limiting enzyme for cholesterol synthesis (198) . SREBP-2 cleavage and HMGCR degradation are two major feedback regulatory mechanisms governing cholesterol biosynthesis (Figures 2A-a) (58) . Recently, the sterol metabolic network was shown to participate in interferon (IFN) antiviral responses (76, 199) . Studies have reported that the IFN regulatory loop mechanism downregulates sterol biosynthesis, linking innate immune responses to viral infection, via sterol metabolism regulation (171) . After viral infection, the infected cells produce high IFN levels, thereby reducing enzyme expression in the cholesterol pathway (171) . On the one hand, the sterol metabolic network is involved in IFN antiviral responses (76) with reduced flux through the mevalonate pathway leading to upregulation of type I IFN responses (172) (Figures 2A-b, d) . IFN-g induces proteasomal degradation of HMG-CoA reductase and the rapid proteasomal elimination of HMG-CoA reductase by IFN-g in primary macrophages which requires endogenous 25HC synthesis (200) . On the other hand, cholesterol metabolism and mevalonate pathways are crucial for regulator T-cells which efficiently drive regulatory T cell proliferation and enhance and stabilize their suppressive capacity (201, 202) . In particular, LKB1 triggered activation of the mevalonate pathway by upregulating IFN-g and IL-17A levels, which were essential for the stabilization of T regulatory cells (201) . Cholesterol is required for SARS-CoV-2 to form pathological syncytia which is believed to help replicate and evade host immune responses (67) . For example, cholesterol biosynthesis pathways are affected by SARS-CoV which regulate levels of SREBP2, S1 protein, peroxisome proliferators-activated receptors g (PPARg), diacylglycerol acyltransferase-1or cholesterol efflux regulatory protein (203) (204) (205) . COVID-19-activated SREBP2 disturbs cholesterol biosynthesis ( Figures 2B-e) , leading to a cytokine storm (50) (Figures 2 B-j) . Importantly, SREBP-2 activity is regulated by crosstalk between cholesterol consumption and nuclear factor k-B (NF-kB) expression from various inflammatory response processes induced by SARS-CoV-2 infection ( Figures 2B-h) (50) . In addition, a metabolic configuration is induced by SREBPs where glucose is metabolized via the citrate malate shuttle, thus enabling natural killer cell growth, proliferation, and function (206) . Therefore, SREBP-dependent lipidomic reprogramming may be viewed as a broad-spectrum antiviral target (203) . 25HC exerts inflammatory properties and significantly attenuates proteolytic processing of SREBP2 (Figures 2A-c) , thereby inhibiting the isoprenoid branch of the mevalonate pathway (207) . 25HC also amplifies inflammatory signals (207) , with growing evidence suggesting it has a broad impact on innate and adaptive immunity (195, (208) (209) (210) (211) (212) (213) , including antiviral immunity, inflammasome activation, and antibody class switching (214) , In addition, lung-selective 25HC nano-therapeutics may function as inhibitors of COVID-19-mediated cytokine storms (215) . IFN-b production may be regulated by targeting the 7dehydrocholesterol reductase (DHCR7) and adding 7dehydrocholesterol (7-DHC), an intermediate natural product in the cholesterol metabolism pathway (77) (Figures 2A-b) . Moreover, it is possible to enhance anti-viral immunity by promoting serine/ threonine kinase 3 (AKT3) activation (77); a positive feedback loop is formed via type I IFN signaling and 7DHC accumulation to amplify innate immune responses and control viral infection by activating AKT3. Also, the emergence of highly pathogenic viruses may be inhibited by DHCR7 inhibitors and 7-DHC (216). York et al. suggested that a reduction in cholesterol biosynthesis was a key event in inducing antiviral responses in virus-infected cells (172) and that decreased cholesterol biosynthesis facilitated anti-viral signaling by the stimulator of interferon gene (STING) in the ER (Figures 2A-d) (216) . Although cholesterol is a crucial component of immune cell membranes, cholesterol accumulation in lymphoid organs promoted T cell priming and stimulated the production of the B cell growth factors, Baff and April (217) . Ito et al. (2016) reported that defects in cholesterol metabolism in CD11c + immune cells resulted in impaired antigen presentation and ultimately autoimmune disease (218) . Excessive cholesterol may exert immune dysfunction and promote excessive pulmonary and systemic inflammatory responses (219).

Recently, several commonly prescribed medications were shown to interfere with sterol biosynthesis, including haloperidol, aripiprazole, cariprazine, fluoxetine, trazodone, and amiodarone (220) . Cholesterol-modifying drugs exert anti-viral roles by reducing the absorption or synthesis of systemic cholesterol or directly changing cholesterol levels in target cell membranes (219) ( Figure 1A) . It is possible to alter the SARS-CoV-2 cycle in vitro and in vivo using various cholesterol-modifying drugs (e.g., AM580 is a selective retinoic acid receptor alpha (RAR-a) agonist, fibrates, and statins) which hinder fatty acid and cholesterol synthesis ( Figure 1E ) (221) . In fact, cholesterol-binding agents, including statins or MbCD, affect cholesterol and destroy lipid rafts, thereby damaging coronavirus adhesion and binding properties (119, 222) . Moreover, these compounds also block key downstream virus infectivity molecules, reduce proinflammatory tumor necrosis factor-a (TNF-a) and IL-6 levels, and/or affect autophagic processes in viral replication and clearance (222) . It is worth noting that cholesterol, fatty acids, cytosolic phospholipase A2a (cPLA2a), and fatty acid synthase contribute to SARS-CoV-2 DMV formation (204, 223) . For example, fenofibrate (reduces triglyceride and low-density lipoprotein cholesterol levels inhibit SARS-CoV-2 replication and pathogenesis by affecting lipid metabolism pathways in the lung cells of patients with COVID-19 (224) . AM580 is a retinoid derivative which interacts with N-terminal SREBP to block lipogenic transactivation (203) . Statins reduce intra-and extra-cellular cholesterol by targeting HMGCR (Figures 2A-a) (225, 226) , thereby affecting viral infection, immunity, and inflammation (219). Statins may also limit inflammation by altering HMGCR mediators in the cholesterol biosynthesis pathway (227, 228) . These anti-inflammatory properties are considered statin's core protective effects in cardiovascular disease, in addition to lowering cholesterol levels (225) . Wang et al. suggested that high cholesterol levels increased entry of pseudotyped SARS-CoV-2 and the infection of virus particles, and more of the receptor ACE2 can be recruited to the internalization site (229) . Statins ability to decrease lipids, enhance protective immune responses, and exert anti-inflammatory properties are beneficial during SARS-CoV-2 infections (219). Statin therapy was previously reported to increase blood clearance rates in chronic HCV infections and reduce mortality and intubation requirements during influenza infection (118) . Statins, especially pitavastatin, may significantly inhibit activity of SARS-CoV-2's main protease, Mpro, which has a greater binding energy than proteases or polymerase inhibitors (230) . Decreasing cellular cholesterol may also trigger the intake of more cholesterol from the blood, reducing serum HDL-cholesterol (HDL-C) and LDL-C levels. As cholesterol-lowering drugs, statins are widely used in cardiovascular and metabolic diseases (231, 232) . They inhibit inflammation by reducing cholesterol and phospholipid deposition in blood vessels. Thus, anti-inflammatory molecules provide protective effects in cardiovascular diseases, and do not just lower cholesterol (225) .

SARS-CoV-2 infection reshapes cholesterol metabolism via gene activation and increased host metabolism activity (23) ( Figure 2B) . Briefly, SARS-CoV-2 infection disturbs cholesterol biosynthesis by activating SREBP-2 and affecting glucose or glutamine metabolism (50, 233) (Figures 2B-e, c, d) . Clinical data has also indicated that lipid disorders may facilitate increased COVID-19 mediated pathogenicity, therefore lowering cholesterol levels may inhibit SARS-CoV-2 replication and viral loads in patients (51, 65) . When compared with healthy individuals, patients with dyslipidemia-related diseases are more likely to be infected by SARS-CoV-2 (234, 235) . Also, SARS-CoV-2 infection caused some COVID-19 patients to have lower serum cholesterol levels (e.g., 27HC, total cholesterol, high density lipoprotein cholesterol, and low-density lipoprotein cholesterol), while triglyceride and nonesterified polyunsaturated fatty acid levels were up-regulated ( Figures 2B-b) (27, (236) (237) (238) . In particular, decreased serum HDL-C levels are positively correlated with COVID-19 infection severity (239) . As infection worsens, serum TC and HDL are lowered, but upon recovery, cholesterol levels return to normal (65, (239) (240) (241) (242) (243) . This may be due to SARS-CoV-2 S proteins affecting HDL functions by removing lipids from HDL and remodeling its composition/structure (243), potentially affecting virus clearance in infected patients (244) . Thus, serum cholesterol and lipoprotein marker monitoring may have an important clinical value for COVID-19 risk prediction (115) . Increased triglyceride/HDL-C ratios may be useful for the early identification of patients with high risk and poor outcomes (245, 246) . Moreover, in patients with severe disease, significantly elevated serum HDL levels are associated with favorable outcomes (112) . HDL-C levels decrease significantly in critically ill COVID-19 patients and are negatively correlated with C-reactive protein and IL-6 levels, however lymphocyte levels are increased with increased HDL-C levels, which positively correlate with the COVID-19 severity (247). Therefore, LDL-C levels may be used as predictors of COVID-19 progression and risk assessment (248) .

SREBP is a membrane junction protein attached to the ER and nuclear envelope (249) ; it regulates the effective synthesis of fat and cholesterol and plays important roles in maintaining energy homeostasis ( Figures 2B-g) (250, 251) . The SREBP protein family regulate lipid cholesterol and fatty acid gene expression via mitogen-activated protein kinase (MAPK) signaling (252) . A recent study reported that SREBP-2 C-terminal fragment was detected for the first time in the blood of patients with COVID-19. Based on data from clinical samples, SREBP-2 C-term was suggested as a reference indicator to assess disease severity after SARS-CoV-2 infection (50) . SREBP-2-dependent lipidomic reprogramming is a broad-spectrum antiviral target, with SREBP-2 activation correlating with COVID-19-induced cytokine storm activation (235) . AM580 strongly inhibits coronavirus replication by interacting with SREBP-2 (203, 204) .

Viruses are intracellular parasitic pathogens. They exploit host nutrients and metabolites to accommodate their survival and are highly adaptable molecules in escaping host antiviral responses. Therefore, interventions in host specific metabolic pathways could become potential antiviral targets (80, 203, 205, 253) . Potential cholesterol-modifying drugs exert broad-spectrum antiviral effects by inhibiting activities of key rate-limiting enzymes in the mevalonate pathway, and also SREBP proteins which regulate host cholesterol homeostasis, thereby affecting coronavirus entry, membrane fusion, and pathological syncytia formation (204) . Thus, cholesterol metabolism disorder is a double-edged sword; it affects the normal physiological functions of cells, however, weaponizing cholesterol dysregulation in local cell environments such as lipid rafts or endosomes could inhibit coronavirus replication. Therefore, the development of selective cholesterol-modifying drugs targeting key cellular components such as lipid rafts and endosomes in infected cells could be a promising antiviral strategy for the early stages of coronavirus infection.

CD and XQ conceived the review concept and drafted the article. JD and HW wrote the original draft and prepared figures. YL, LT, YS, CS, and WL edited and reviewed the manuscript. All authors read and agreed to the final published version of the manuscript.

Identification of a Novel Coronavirus in Patients With Severe Acute Respiratory Syndrome

The Structure and Functions of Coronavirus Genomic 3' and 5' Ends

Origin and Evolution of Pathogenic Coronaviruses

From Sars to Mers, Thrusting Coronaviruses Into the Spotlight

The Emerging Novel Middle East Respiratory Syndrome Coronavirus: The "Knowns" and "Unknowns

Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein

From Sars to Sars-Cov-2, Insights on Structure, Pathogenicity and Immunity Aspects of Pandemic Human Coronaviruses

Evidence for Sars-Cov-2 Related Coronaviruses Circulating in Bats and Pangolins in Southeast Asia

Structural Insights Into Coronavirus Entry

Sars-Coronavirus Ancestor's Foot-Prints in South-East Asian Bat Colonies and the Refuge Theory

Broad Cross-Species Infection of Cultured Cells by Bat Hku2-Related Swine Acute Diarrhea Syndrome Coronavirus and Identification of Its Replication in Murine Dendritic Cells Highlight Its Potential for Diverse Interspecies Transmission

Fatal Swine Acute Diarrhoea Syndrome Caused by an Hku2-Related Coronavirus of Bat Origin

Structural Analysis of Major Species Barriers Between Humans and Palm Civets for Severe Acute Respiratory Syndrome Coronavirus Infections

A Novel Coronavirus From Patients With Pneumonia in China

Coronavirus Biology and Replication: Implications for Sars-Cov-2

Covid-19: Discovery, Diagnostics and Drug Development

The Deadly Coronaviruses: The 2003 Sars Pandemic and the 2020 Novel Coronavirus Epidemic in China

The First 75 Days of Novel Coronavirus (Sars-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment

Susceptibility of Ferrets, Cats, Dogs, and Other Domesticated Animals to Sars-Coronavirus 2

Covid-19 and the Cardiovascular System: A Comprehensive Review

Treatment for Covid-19: An Overview

Sars-CoV-2 Induces Transcriptional Signatures in Human Lung Epithelial Cells That Promote Lung Fibrosis

Sars-CoV-2 Binds Platelet Ace2 to Enhance Thrombosis in Covid-19

Glucocorticoids Improve Severe or Critical Covid-19 by Activating Ace2 and Reducing Il-6 Levels

Current Advances in the Development of Sars-CoV-2 Vaccines

Alterations of Lipid Profile in Covid-19: A Narrative Review

An Interactive Web-Based Dashboard to Track Covid-19 in Real Time

Identification of Multipotent Drugs for Covid-19 Therapeutics With the Evaluation of Their Sars-CoV2 Inhibitory Activity

Recent Developments on Therapeutic and Diagnostic Approaches for Covid-19

Does Sars-Cov-2 Bind to Human Ace2 More Strongly Than Does Sars-CoV?

Emerging Sars-CoV-2 Variants of Concern and Potential Intervention Approaches

Confirmed Reinfection With Sars-CoV-2 Variant Voc-202012/01

Sars-CoV-2 Delta Voc in Scotland: Demographics, Risk of Hospital Admission, and Vaccine Effectiveness

Early Transmissibility Assessment of the N501y Mutant Strains of Sars-CoV-2 in the United Kingdom

Sars-CoV-2 Variants Combining Spike Mutations and the Absence of Orf8 May Be More Transmissible and Require Close Monitoring

Sars-CoV-2 Genomic Surveillance in Taiwan Revealed Novel Orf8-Deletion Mutant and Clade Possibly Associated With Infections in Middle East

Emergence of European and North American Mutant Variants of Sars-CoV-2 in South-East Asia

Detection of the New Sars-CoV-2 Variants of Concern B.1.1.7 and B.1.351 in Five Sars-CoV-2 Rapid Antigen Tests (Rats)

Two-Step Strategy for the Identification of Sars-CoV-2 Variant of Concern 202012/01 and Other Variants With Spike Deletion H69-V70, France

Emergence of Sars-CoV-2 B.1.1.7 Lineage -United States

The First Sars-CoV-2 Genetic Variants of Concern (Voc) in Poland: The Concept of a Comprehensive Approach to Monitoring and Surveillance of Emerging Variants

Investigation of an Outbreak of Symptomatic Sars-CoV-2 Voc 202012/01-Lineage B.1.1.7 Infection in Healthcare Workers, Italy

Sars-CoV-2 Variants Lacking Orf8 Occurred in Farmed Mink and Pangolin

Sars-CoV-2 Infection in Farmed Minks, Associated Zoonotic Concerns, and Importance of the One Health Approach During the Ongoing Covid-19 Pandemic

Sars-CoV-2 in Animals: Potential for Unknown Reservoir Hosts and Public Health Implications

Covid-19 in People With Diabetes: Understanding the Reasons for Worse Outcomes

Pre-Infection Hdl-Cholesterol Levels and Mortality Among Elderly Patients Infected With Sars-CoV-2

Diabetes, Obesity, Metabolism, and Sars-CoV-2 Infection: The End of the Beginning

Covid-19-Activated Srebp2 Disturbs Cholesterol Biosynthesis and Leads to Cytokine Storm

Association of Serum Hdl-Cholesterol and Apolipoprotein A1 Levels With Risk of Severe Sars-CoV-2 Infection

Age-Specific Mortality and Immunity Patterns of Sars-CoV-2

Clinical Course and Prognostic Factors of Covid-19 Infection in an Elderly Hospitalized Population

Impact of Obesity and Sars-CoV-2 Infection: Implications for Host Defence -A Living Review

Trained Immunity as a Novel Approach Against Covid-19 With a Focus on Bacillus Calmette-Gueŕin Vaccine: Mechanisms, Challenges and Perspectives

Clinical Characteristics of Covid-19 in New York City

Viral and Host Transcriptomes in Sars-CoV-2 Infected Human Lung Cells

Mechanisms and Regulation Of Cholesterol Homeostasis

Cholesterol Access Aids Pathogen Spread

Cholesterol Binding to the Transmembrane Region of a Group 2 Hemagglutinin (Ha) of Influenza Virus Is Essential for Virus Replication, Affecting Both Virus Assembly and Ha Fusion Activity

Target Membrane Cholesterol Modulates Single Influenza Virus Membrane Fusion Efficiency But Not Rate

Ebola Virus Glycoprotein Interacts With Cholesterol to Enhance Membrane Fusion and Cell Entry

Cholesterol in Quarantine

Differential Effect of Cholesterol on Type I and Ii Feline Coronavirus Infection

Cholesterol: A New Game Player Accelerating Vasculopathy Caused by Sars-CoV-2?

Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide

Sars-CoV-2 Requires Cholesterol for Viral Entry and Pathological Syncytia Formation

Requirements for Ceacams and Cholesterol During Murine Coronavirus Cell Entry

Multifaceted Roles for Lipids in Viral Infection

Hepatitis C Virus Hijacks Host Lipid Metabolism

Modulation of Host Lipid Metabolism by Hepatitis C Virus: Role of New Therapies

Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism

Genome-Scale Metabolic Modeling Reveals Sars-CoV-2-Induced Host Metabolic Reprogramming and Identifies Metabolic Antiviral Targets

Lipidomics Issues on Human Positive Ssrna Virus Infection: An Update

Bis (Monoacylglycero)Phosphate, an Important Actor in the Host Endocytic Machinery Hijacked by Sars-CoV-2 and Related Viruses

The Transcription Factor Stat-1 Couples Macrophage Synthesis of 25-Hydroxycholesterol to the Interferon Antiviral Response

Targeting 7-Dehydrocholesterol Reductase Integrates Cholesterol Metabolism and Irf3 Activation to Eliminate Infection

The Role of Host Cholesterol During Flavivirus Infection

Potential Covid-19 Therapeutics From a Rare Disease: Weaponizing Lipid Dysregulation to Combat Viral Infectivity

Lipid Homeostasis and Mevalonate Pathway in Covid-19: Basic Concepts and Potential Therapeutic Targets

Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling Upon Coronavirus Replication

Identification of Required Host Factors for Sars-CoV-2 Infection in Human Cells

Modulating the Transcriptional Landscape of Sars-CoV-2 as an Effective Method for Developing Antiviral Compounds

Genetic Screens Identify Host Factors for Sars-CoV-2 and Common Cold Coronaviruses

Role of Lipids in Virus Replication

Subversion of the Actin Cytoskeleton During Viral Infection

Sars-CoV-2 Cell Entry Depends on Ace2 and Tmprss2 and Is Blocked by a Clinically Proven Protease Inhibitor

Two-Step Conformational Changes in a Coronavirus Envelope Glycoprotein Mediated by Receptor Binding and Proteolysis

Dependence of Sars-CoV-2 Infection on Cholesterol-Rich Lipid Raft and Endosomal Acidification

Protease-Mediated Enhancement of Severe Acute Respiratory Syndrome Coronavirus Infection

Infectious Bronchitis Virus Entry Mainly Depends on Clathrin Mediated Endocytosis and Requires Classical Endosomal/Lysosomal System

Porcine Hemagglutinating Encephalomyelitis Virus Enters Neuro-2a Cells Via Clathrin-Mediated Endocytosis in a Rab5-, Cholesterol-, and Ph-Dependent Manner

Pedv Enters Cells Through Clathrin-, Caveolae-, and Lipid Raft-Mediated Endocytosis and Traffics Via the Endo-/ Lysosome Pathway

Endocytic Pathway of Feline Coronavirus for Cell Entry: Differences in Serotype-Dependent Viral Entry Pathway

Stabilized Coronavirus Spikes Are Resistant to Conformational Changes Induced by Receptor Recognition or Proteolysis

Activation of the Sars Coronavirus Spike Protein Via Sequential Proteolytic Cleavage at Two Distinct Sites

Coronaviruses Post-Sars: Update on Replication and Pathogenesis

Structure, Function, and Evolution of Coronavirus Spike Proteins

Hdl-Scavenger Receptor B Type 1 Facilitates Sars-CoV-2 Entry

A Genome-Wide Crispr Screen Identifies Host Factors That Regulate Sars-CoV-2 Entry

Cell Entry Mechanisms of Sars-CoV-2

The N-Terminal Domain of the Murine Coronavirus Spike Glycoprotein Determines the Ceacam1 Receptor Specificity of the Virus Strain

Neurovirulent Murine Coronavirus Jhm.Sd Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion

Structure of Mouse Coronavirus Spike Protein Complexed With Receptor Reveals Mechanism for Viral Entry

Conformational Changes in the Spike Glycoprotein of Murine Coronavirus Are

Degrees C Either by Soluble Murine Ceacam1 Receptors or by Ph 8

Improvement in Lipid and Protein Trafficking in Niemann-Pick C1 Cells by Correction of a Secondary Enzyme Defect

Npc1-Regulated Dynamic of Clathrin-Coated Pits Is Essential for Viral Entry

Ebola Virus Entry Requires the Cholesterol Transporter Niemann-Pick C1

Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence That Transport to Npc1+ Endolysosomes Is a Rate-Defining Step

The Lysosome: A Potential Juncture Between Sars-CoV-2 Infectivity and Niemann-Pick Disease Type C, With Therapeutic Implications

Targeting the Endolysosomal Host-Sars-CoV-2 Interface by Clinically Licensed Functional Inhibitors of Acid Sphingomyelinase (Fiasma) Including the Antidepressant Fluoxetine

Cholesterol Metabolism-Impact for Sars-CoV-2 Infection Prognosis, Entry, and Antiviral Therapies

Sars Coronavirus Entry Into Host Cells Through a Novel Clathrin-and Caveolae-Independent Endocytic Pathway

Natural Small Molecules as Inhibitors of Coronavirus Lipid-Dependent Attachment to Host Cells: A Possible Strategy for Reducing Sars-CoV-2 Infectivity?

Cholesterol, Lipoproteins, and Covid-19: Basic Concepts and Clinical Applications

Hematopoiesis Is Regulated by Cholesterol Efflux Pathways and Lipid Rafts: Connections With Cardiovascular Diseases

Lipid Rafts Play an Important Role in the Early Stage of Severe Acute Respiratory Syndrome-Coronavirus Life Cycle

Cholesterol in Relation to Covid-19: Should We Care About It?

The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain

Lipid Rafts Are Involved in Sars-CoV Entry Into Vero E6 Cells

Importance of Cholesterol-Rich Membrane Microdomains in the Interaction of the S Protein of Sars-Coronavirus With the Cellular Receptor Angiotensin-Converting Enzyme 2

Cholesterol Is Important for a Post-Adsorption Step in the Entry Process of Transmissible Gastroenteritis Virus

Murine Coronavirus Requires Lipid Rafts for Virus Entry and Cell-Cell Fusion But Not for Virus Release

Cholesterol 25-Hydroxylase Suppresses Sars-CoV-2 Replication by Blocking Membrane Fusion

Cholesterol 25-Hydroxylase Inhibits Sars-CoV-2 and Other Coronaviruses by Depleting Membrane Cholesterol

Structural Basis for the Recognition of Sars-CoV-2 by Full-Length Human Ace2

Importance of Cholesterol for Infection of Cells by Transmissible Gastroenteritis Virus

Spiking Dependence of Sars-CoV-2 Pathogenicity on Tmprss2

Contributions of Human Ace2 and Tmprss2 in Determining Host-Pathogen Interaction of Covid-19

Sars-CoV-2 Omicron Variant Shows Less Efficient Replication and Fusion Activity When Compared With Delta Variant in Tmprss2-Expressed Cells

Antiandrogens Target Tmprss2 and Reduce Sars-CoV-2 Virus Entry in Lung Cells

The Antiandrogen Enzalutamide Downregulates Tmprss2 and Reduces Cellular Entry of Sars-CoV-2 in Human Lung Cells

Molecular Mechanism of Sars-CoV-2 Cell Entry Inhibition Via Tmprss2 by Camostat and Nafamostat Mesylate

Alpha-1 Antitrypsin Inhibits Tmprss2 Protease Activity and Sars-CoV-2 Infection

Racial Variations in Covid-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated With Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for Covid-19?

Androgen-Deprivation Therapies for Prostate Cancer and Risk of Infection by Sars-CoV-2: A Population-Based Study (N = 4532)

Absence of Correlation Between Oxysterol Accumulation in Lipid Raft Microdomains, Calcium Increase, and Apoptosis Induction on 158n Murine Oligodendrocytes

27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of Il6-Jak-Stat3 Signaling in Prostate Cancer Cells

Methyl-b-Cyclodextrin Induces Programmed Cell Death in Chronic Myeloid Leukemia Cells and, Combined With Imatinib, Produces a Synergistic Downregulation of Erk/Spk1 Signaling

Porcine Deltacoronavirus Activates the Raf/Mek/Erk Pathway to Promote Its Replication

Jnk and P38 Mitogen-Activated Protein Kinase Pathways Contribute to Porcine Epidemic Diarrhea Virus Infection

Upregulation of Dusp6 Impairs Infectious Bronchitis Virus Replication by Negatively Regulating Erk Pathway and Promoting Apoptosis

Extracellular Signal-Regulated Kinase (Erk) Activation Is Required for Porcine Epidemic Diarrhea Virus Replication

Suppression of Coronavirus Replication by Inhibition of the Mek Signaling Pathway

Interferon-Mediated Reprogramming of Membrane Cholesterol to Evade Bacterial Toxins

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

Cholesterol Enhances Mouse Hepatitis Virus-Mediated Cell Fusion

25-Hydroxycholesterol Is a Potent Sars-CoV-2 Inhibitor

Cholesterol and Statins: Involvement and Application for Covid-19

The Antiviral Effector Ifitm3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry

Lysobisphosphatidic Acid Controls Endosomal Cholesterol Levels

Cholesterol 25-Hydroxylase Negatively Regulates Porcine Intestinal Coronavirus Replication by the Production of 25-Hydroxycholesterol

Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol

Cholesterol Is Important for the Entry Process of Porcine Deltacoronavirus

Opposing Activities of Ifitm Proteins in Sars-CoV-2 Infection

Ifitm Proteins Inhibit Entry Driven by the Mers-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms

Ifitm Proteins Restrict Viral Membrane Hemifusion

Identification of Residues Controlling Restriction Versus Enhancing Activities of Ifitm Proteins on Entry of Human Coronaviruses

The Molecular Biology of Coronaviruses

Human Coronavirus: Host-Pathogen Interaction

Architecture and Biogenesis of Plus-Strand Rna Virus Replication Factories

Hepatitis C Virus Replication Depends on Endosomal Cholesterol Homeostasis

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (Sars-CoV-2) Oxysterol Derivatives In Vitro

Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection

Cholesterol Manipulation by West Nile Virus Perturbs the Cellular Immune Response

Nef Increases the Synthesis of and Transports Cholesterol to Lipid Rafts and Hiv-1 Progeny

How Cells Handle Cholesterol

Targeted Deletion of Hepatocyte Abca1 Increases Plasma Hdl (High-Density Lipoprotein) Reverse Cholesterol Transport Via the Ldl (Low-Density Lipoprotein) Receptor

Targeting Cholesterol Metabolism in Glioblastoma: A New Therapeutic Approach in Cancer Therapy

Cholesterol Synthesis Inhibitor U18666a and the Role of Sterol Metabolism and Trafficking in Numerous Pathophysiological Processes

The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response

Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I Ifn Signaling

Coronavirus M Proteins Accumulate in the Golgi Complex Beyond the Site of Virion Budding

Cholesterol Biosynthesis Modulation Regulates Dengue Viral Replication

The Increase in Cholesterol Levels at Early Stages After Dengue Virus Infection Correlates With an Augment in Ldl Particle Uptake and Hmg-Coa Reductase Activity

Cholesterol Depletion of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus With Beta-Cyclodextrin Inactivates and Permeabilizes the Virions: Evidence for Virion-Associated Lipid Rafts

Envelope Lipid-Packing as a Critical Factor for the Biological Activity and Stability of Alphavirus Particles Isolated From Mammalian and Mosquito Cells

Current Understanding of the Role of Cholesterol in the Life Cycle of Alphaviruses

Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery Against Zika and Other Flaviviruses

Flux Analysis of Cholesterol Biosynthesis in Vivo Reveals Multiple Tissue and Cell-Type Specific Pathways

Simplified Lc-Ms Method for Analysis of Sterols in Biological Samples

Steroidal Triterpenes of Cholesterol Synthesis

25-Hydroxycholesterol and 27-Hydroxycholesterol Inhibit Human Rotavirus Infection by Sequestering Viral Particles Into Late Endosomes

Multifaceted Functions of Ch25h and 25hc to Modulate the Lipid Metabolism, Immune Responses, and Broadly Antiviral Activities

25-Hydroxycholesterol Protects Host Against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model

25-Hydroxycholesterol Production by the Cholesterol-25-Hydroxylase Interferon-Stimulated Gene Restricts Mammalian Reovirus Infection

25-Hydroxycholesterol Inhibition of Lassa Virus Infection Through Aberrant Gp1 Glycosylation

Cholesterol 25-Hydroxylase Inhibits Encephalomyocarditis Virus Replication Through Enzyme Activity-Dependent and Independent Mechanisms

Porcine Reproductive and Respiratory Syndrome Virus E Protein Degrades Porcine Cholesterol 25-Hydroxylase Via the Ubiquitin-Proteasome Pathway

Cholesterol 25-Hydroxylase Suppresses Porcine Deltacoronavirus Infection by Inhibiting Viral Entry

Modulation of Cell Proteome by 25-Hydroxycholesterol and 27-Hydroxycholesterol: A Link Between Cholesterol Metabolism and Antiviral Defense

Vitamin D and Lumisterol Novel Metabolites Can Inhibit Sars

Replication Machinery Enzymes

Building Viral Replication Organelles: Close Encounters of the Membrane Types

Viral Innate Immune Evasion and the Pathogenesis of Emerging Rna Virus Infections

Armand-Frappier Outstanding Student Award -the Emerging Role of 25-Hydroxycholesterol in Innate Immunity 1

Host Defense Against Viral Infection Involves Interferon Mediated Down-Regulation of Sterol Biosynthesis

Endogenous Sterol Intermediates of the Mevalonate Pathway Regulate Hmgcr Degradation and Srebp-2 Processing

How Low Cholesterol Is Good for Anti-Viral Immunity

Rapid Proteasomal Elimination of 3-Hydroxy-3-Methylglutaryl-Coa Reductase by Interferon-G in Primary Macrophages Requires Endogenous 25-Hydroxycholesterol Synthesis

Activation of Mevalonate Pathway Via Lkb1 Is Essential for Stability of T Cells

Mtorc1 Couples Immune Signals and Metabolic Programming to Establish T(Reg)-Cell Function

Srebp-Dependent Lipidomic Reprogramming as a Broad-Spectrum Antiviral Target

The Role of Lipid Metabolism in Covid-19 Virus Infection and as a Drug Target

Lipid Droplets Fuel Sars-CoV-2 Replication and Production of Inflammatory Mediators

Srebp-Controlled Glucose Metabolism Is Essential for Nk Cell Functional Responses

25-Hydroxycholesterol Acts as an Amplifier of Inflammatory Signaling

25-Hydroxycholesterols in Innate and Adaptive Immunity

25-Hydroxycholesterol Amplifies Microglial Il-1b Production in an Apoe Isoform-Dependent Manner

Cholesterol 25-Hydroxylase Promotes Efferocytosis and Resolution of Lung Inflammation

Oxysterol Sensing Through the Receptor Gpr183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation

25-Hydroxycholesterol Enhances Cytokine Release and Toll-Like Receptor 3 Response in Airway Epithelial Cells

Integrin Activation by the Lipid Molecule 25-Hydroxycholesterol Induces a Proinflammatory Response

Oxysterols Provide Innate Immunity to Bacterial Infection by Mobilizing Cell Surface Accessible Cholesterol

Lung-Selective 25-Hydroxycholesterol Nanotherapeutics as a Suppressor of Covid-19-Associated Cytokine Storm

Sterol)Ized Immunity: Could Pi3k/Akt3 Be the Answer? Immunity (2020)

Cholesterol Accumulation in Cd11c Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease

Immune Cell Intolerance for Excess Cholesterol

Cholesterol-Modifying Drugs in Covid-19

Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (Covid-19)

Targeting Lipid Rafts as a Strategy Against Coronavirus

Viral Rewiring of Cellular Lipid Metabolism to Create Membranous Replication Compartments

Molecular Basis of Quercetin as a Plausible Common Denominator of Macrophage-Cholesterol-Fenofibrate Dependent Potential Covid-19 Treatment Axis

Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms

Sterols and Oxysterols in Immune Cell Function

The Pharmacology of Statins

Diabetogenic Action of Statins: Mechanisms

The Role of High Cholesterol in Age-Related Covid19 Lethality. bioRxiv

Statins and the Covid-19 Main Protease: Evidence on Direct Interaction

Pleiotropic Effects of Statins on the Cardiovascular System

Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring

Sars-CoV-2 Infection Rewires Host Cell Metabolism and Is Potentially Susceptible to Mtorc1 Inhibition

Cutting Edge: Severe Sars-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators

Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in Covid-19

High Plasma Concentration of Non-Esterified Polyunsaturated Fatty Acids Is a Specific Feature of Severe Covid-19 Pneumonia

Lipoprotein Concentrations Over Time in the Intensive Care Unit Covid-19 Patients: Results From the Apocovid Study

The Cholesterol Metabolite 27-Hydroxycholesterol Inhibits Sars-CoV-2 and Is Markedly Decreased in Covid-19 Patients

Declined Serum High Density Lipoprotein Cholesterol Is Associated With the Severity of Covid-19

Clin Chim Acta

Low Serum Cholesterol Level Among Patients With Covid-19 Infection in Wenzhou

Low High-Density Lipoprotein Level Is Correlated With the Severity of Covid-19 Patients: An Observational Study

Low Total Cholesterol Blood Level Is Correlated With Pulmonary Severity in Covid-19

Sars-CoV-2 Spike Protein Removes Lipids From Model Membranes and Interferes With the Capacity of High Density Lipoprotein to Exchange Lipids

High-Density Lipoprotein Cholesterol as a Factor Affecting Virus Clearance in Covid-19

Triglyceride to High-Density Lipoprotein Cholesterol Ratio Is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study

Baseline Cardiometabolic Profiles and Sars-CoV-2 Risk in the Uk Biobank

Hypolipidemia Is Associated With the Severity of Covid-19

Letter to the Editor: Low-Density Lipoprotein Is a Potential Predictor of Poor Prognosis in Patients With Coronavirus Disease

Independent Regulation of Sterol Regulatory Element-Binding Proteins 1 and 2 in Hamster Liver

The Srebp Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor

Srebp-1, a Basic-Helix-Loop-Helix-Leucine Zipper Protein That Controls Transcription of the Low Density Lipoprotein Receptor Gene

Srebps: Activators of the Complete Program of Cholesterol and Fatty Acid Synthesis in the Liver

Evidences for Lipid Involvement in Sars-CoV-2 Cytopathogenesis

This work was supported by the National Natural Science Foundation of China (Grant No. 32030108), the Foundation of Key Laboratory of Veterinary Biotechnology (No. shklab202001), and Natural Science Foundation of Shanghai (Grant No. 21ZR1476800 & 20ZR1469400). We thank International Science Editing (http://www.internationalscienceediting.com) for editing this manuscript. Figures were drafted using BioRender.com. Adapted from "ZIKV Infection Cycle" and "Mechanisms behind the induction of trained Immunity" by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2022 Dai, Wang, Liao, Tan, Sun, Song, Liu, Qiu and Ding. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.